| GE Healthcare AG - Visipaque 320 mg/mL, Injektionslösung |
| 52228 | | 03 | | Visipaque 320 mg/mL | | Injektionslösung | | V08AB09 | | Iodixanol | | 15.04.1994 | | |
|
| Composition |
| iodixanolum 652 mg corresp. iodum 320 mg, trometamolum, natrii calcii edetas, calcii chloridum dihydricum, natrii chloridum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.45 mg. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Iodixanol | 652 mg/ml correspond Iod 320 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Iodixanol | 652 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Calcium Chloride | | Sodium Calcium Edetate | | Sodium Chloride | | Trometamol |
| |
|
|
